Filing Details

Accession Number:
0001209191-19-007373
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-05 16:41:54
Reporting Period:
2019-02-05
Accepted Time:
2019-02-05 16:41:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Plc HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1667903 M. Geoffrey Curtis C/O Horizon Pharma Plc
Connaught House, 1St Fl, 1 Burlington Rd
Dublin L2 4
Evp, Corporate Affairs, Cco No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2019-02-05 5,500 $23.11 32,202 No 4 S Direct
Ordinary Shares Disposition 2019-02-05 2,000 $23.25 30,202 No 4 S Direct
Ordinary Shares Disposition 2019-02-05 1,335 $23.20 28,867 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 420 Indirect By spouse
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on December 13, 2018.